These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9021806)

  • 1. Colony-stimulating factors after the treatment of pediatric malignant diseases.
    Schuler D
    Pediatr Hematol Oncol; 1997; 14(1):iii-v. PubMed ID: 9021806
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy.
    Lifton R; Bennett JM
    Hematol Oncol Clin North Am; 1996 Aug; 10(4):825-39. PubMed ID: 8811304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factors for adjunctive therapy of infections in neutropenic cancer patients.
    Mayordomo JI; Rivera F; Cortes-Funes H
    Support Care Cancer; 1995 Jan; 3(1):84-5. PubMed ID: 7535169
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical applications of hematopoietic growth factors in pediatric oncology.
    Levine JE; Boxer LA
    Curr Opin Hematol; 2002 May; 9(3):222-7. PubMed ID: 11953668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factors stimulate some treatments, continue to evolve.
    Volkers N
    J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
    Mori PG; Pasino M; Dufour C; Boeri E; Molinari AC
    Blood; 1994 Nov; 84(9):3244-5. PubMed ID: 7524771
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
    Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
    Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
    Disis ML
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
    [No Abstract]   [Full Text] [Related]  

  • 9. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 10. Colony-stimulating factors.
    Gordon MS; Gabrilove JL
    Curr Opin Oncol; 1990 Dec; 2(6):1152-8. PubMed ID: 1712236
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactive discussion on chemotherapy-related adverse events.
    Adams VR; Lyman GH
    Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
    [No Abstract]   [Full Text] [Related]  

  • 12. Anesthetic considerations in patients receiving colony-stimulating factors (G-CSF and GM-CSF).
    Tobias JD; Furman WL
    Anesthesiology; 1991 Sep; 75(3):536-8. PubMed ID: 1716081
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autologous transplantation of hematopoietic stem cells and growth factors].
    Harousseau JL
    Pathol Biol (Paris); 1993 Jan; 41(1):50. PubMed ID: 7686287
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of colony stimulating factors in cancer therapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1991; 12():307-26. PubMed ID: 1718376
    [No Abstract]   [Full Text] [Related]  

  • 16. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
    Lehrnbecher T; Creutzig U
    Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony-stimulating factors in the prevention and management of infectious diseases.
    Page AV; Liles WC
    Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 19. Colony-stimulating factors for neutropenia in glycogen storage disease Ib.
    Schroten H; Wendel U; Burdach S; Roesler J; Breidenbach T; Schweitzer S; Zeidler C; Welte K
    Lancet; 1991 Mar; 337(8743):736-7. PubMed ID: 1706047
    [No Abstract]   [Full Text] [Related]  

  • 20. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.